Bill Gates Announces $40 Million Investment in mRNA Research and Vaccine Manufacturing for Low- and Middle-Income Countries
At the 2023 Grand Challenges Annual Meeting, Bill Gates, Co-chair of the Bill & Melinda Gates Foundation, unveiled plans for new investments aimed at advancing access to mRNA research and vaccine manufacturing technology. This initiative is designed to bolster the capacity of low- and middle-income countries (LMICs) in developing high-quality, life-saving vaccines on a large…